Video Experimental Relacionado

Updated: Feb 6, 2026

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Patología de APP-C31 como objetivo en enfermedades neurodegenerativas

King Chi Yip¹, Woon Fei Ho², Yang Liu³

¹Department of Biomedical Science, College of Biomedicine, City University of Hong Kong, Kowloon, 999077, Hong Kong, China.

Journal of biomedical science

|February 4, 2026

Resumen

Los fragmentos C31 de la proteína precursora amiloide (APP-C31) son mediadores clave en la neurodegeneración, actuando como un ejecutor central que une los desencadenantes del estrés con la pérdida neuronal. La comprensión de APP-C31

Área de la Ciencia:

Neurociencia
Biología Molecular
Bioquímica

Sus antecedentes:

Las enfermedades neurodegenerativas implican la pérdida progresiva de neuronas, afectando a millones de personas en todo el mundo.
La proteína precursora de amiloide (APP) y sus productos de escisión, como el APP-C31, están implicados en la neurodegeneración.
La investigación actual se centra en la comprensión de los mecanismos neurodegenerativos y el desarrollo de estrategias terapéuticas.

Objetivo del estudio:

Revisar exhaustivamente la estructura, neurotoxicidad y mecanismos reguladores del APP-C31.
Explorar la relevancia clínica del APP-C31 en enfermedades neurodegenerativas.
Evaluar el potencial terapéutico del APP-C31 como diana farmacológica.

Principales métodos:

Revisión de la literatura existente sobre APP-C31.
Análisis de estudios sobre la estructura y función del APP-C31.
Síntesis de datos sobre el papel del APP-C31 en la patología de la enfermedad.

Principales resultados:

El APP-C31 exhibe una neurotoxicidad significativa.
El APP-C31 se regula a través de complejos mecanismos celulares.
El APP-C31 está relacionado con la patogénesis de diversas afecciones neurodegenerativas.

Conclusiones:

Se postula que el APP-C31 es un "ejecutor central" crítico en la neurodegeneración.
El APP-C31 actúa como un centro de señalización, impulsando múltiples vías patogénicas.
La focalización del APP-C31 ofrece estrategias terapéuticas potenciales para enfermedades neurodegenerativas.

Palabras clave:

Fragmentos de APP-C31 Proteína precursora de amiloide (APP)Enfermedades neurodegenerativas Objetivo terapéutico

Más Videos Relacionados

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

Videos de Conceptos Relacionados

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Principles of Disease Surveillance

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...